In 2018, an estimated 1.7 million new cases of cancer will be diagnosed in the United States and over 600 thousand people will die from the disease. Recently, a phase I trial was conducted testing a personalized vaccine’s ability to hold an aggressive group of cancers in check. The trial is the first step to determining if a vaccine can stop cancer in its tracks. The promising new cancer vaccine cured up to 97 percent of tumors in mice and will soon be tested in humans for the first time. Researchers from Stanford University will test the therapy in about 35 people with lymphoma by the end of... Read More